Tokyo, Sept. 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063068) titled 'A Study on How Video Records Support Understanding of Falls and Planning S... Read More
Tokyo, Sept. 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063059) titled 'A Study Comparing Ketamine plus Tramadol Combination Therapy with Caudal B... Read More
Tokyo, Sept. 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063007) titled 'Regional differences in brain blood flow during orthostatic stress: a stud... Read More
Tokyo, Sept. 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063067) titled 'Safety, Adverse Events, and Pharmacokinetics/Therapeutic Drug Monitoring o... Read More
Tokyo, Sept. 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063065) titled 'A survey of sleep support needs among infants aged 1-2 months and their fa... Read More
Tokyo, Sept. 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063041) titled 'Effects of Continuous Test Food Intake on Bowel Movements: A Randomized, P... Read More
Tokyo, Sept. 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063032) titled 'A Morphological Study of the Spine in Pregnant Women in the Third Trimeste... Read More
Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutam... Read More
Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-086... Read More
Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy W... Read More